Clinical Trial Update: A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update describing a Phase 1/Phase 2 study of QLC5508 and QLH12016 in combination with other anti-tumor therapies for advanced prostate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• QLC5508
• QLH12016

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Advanced Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING